Haleon

Haleon

Haleon is a global consumer health company focused on developing and manufacturing health products that improve everyday health with a strong emphasis on science, innovation, and human understanding. As a key player in the consumer healthcare sector, Haleon’s portfolio covers areas such as oral health, vitamins, minerals and supplements (VMS), and over-the-counter (OTC) medicines including pain relief, respiratory, digestive products, and others. Recognizing the significant impact that legislation and regulatory initiatives can have on its business and innovation capabilities, Haleon actively engages in political advocacy to shape public policy in the interests of consumers, innovation, and public health.

Haleon’s political advocacy approach involves direct engagement with government stakeholders, collaboration with industry organizations at global, regional, and local levels, and partnerships with external organizations such as global professional bodies and advocacy groups. The company develops proactive policy proposals and provides evidence-based perspectives on government initiatives, often commissioning independent research to strengthen the policy case.

The company is committed to transparency, accountability, and integrity in its lobbying activities. It publishes its political advocacy expenditures annually via the European Transparency Register and adheres to strict governance principles and due diligence processes to ensure compliance with local and international laws. Most political engagement is conducted by Haleon employees, with public affairs consultancies primarily providing monitoring and strategic advice. External consultants may participate in meetings but always under Haleon’s policies and oversight.

Haleon targets key EU legislative files such as the revision of the general pharmaceuticals legislation, European Health Data Space, Water Framework Directive, Urban Waste Water Treatment Directive, Cosmetics regulation, Medical Device Regulation, and initiatives on non-communicable diseases. The company also supports transparency in policymaking and publishes its positions on important topics on its website.

Overall, Haleon positions itself as a responsible and transparent actor in EU lobbying, aiming to contribute constructively to policy development that supports consumer health innovation and public health objectives while maintaining high ethical standards

  • Registered in the EU Transparency Register since July 13, 2023

  • Registration ID: 537822650751-41

  • Sector: Consumer Health

  • Main advocacy focus: Pharmaceuticals legislation, health data, environmental directives, cosmetics, medical devices, and non-communicable diseases

  • Political advocacy conducted primarily by Haleon employees with support from public affairs consultancies

  • Committed to transparency and publishes lobbying expenditures annually

No related lobbyists found.

  • Pharmaceuticals and Healthcare

  • Consumer Health Products

  • Public Health Policy

  • Environmental Regulation (Water Framework, Waste Water Treatment)

  • Cosmetics Regulation

  • Medical Devices

  • Data and Health Information Policy

  • Works with government stakeholders at global, regional, and local levels

  • Collaborates with industry organizations worldwide

  • Partners with global professional bodies and advocacy organizations aligned with policy goals

  • Uses public affairs consultancies for monitoring and strategy

  • Engages with trade and business associations (details published on Haleon’s website)

  • Haleon publishes annual costs associated with engaging EU institutions via the European Transparency Register.

  • Exact financial expenditure breakdown by year since registration in July 2023 is not detailed in the publicly available documents.

  • The company ensures management oversight and due diligence for all political advocacy expenditures, including payments to third parties.

  • Registered with the European Transparency Register since July 2023

  • Interacts with the European Commission, European Parliament, and other EU institutions relevant to health, pharmaceuticals, environment, and data policy

  • Complies with the EU Transparency Register code of conduct and governance principles

  • Since registration in July 2023, Haleon employees and occasionally external consultants have held meetings with EU policymakers and stakeholders.

  • Specific details of meetings, including dates and participants, are not publicly enumerated in the available sources.